A synthetic peptide elicits antibodies reactive with the external glycoprotein of human T cell lymphotropic virus type I Free

Abstract

A synthetic peptide derived from the external glycoprotein of human T cell lymphotropic virus type I (HTLV-I) (Env-5; amino acids 242 to 256) reacted with IgG antibodies in serum specimens from HTLV-I-infected individuals. C-terminal residues of Env-5 were crucial for the antibody reactivity. Polyclonal rabbit antibodies to Env-5 did not inhibit syncytium formation but such antibodies reacted specifically with gp68 and gp46 glycoproteins of HTLV-I in an immunoblot analysis. Immunoprecipitation of the surface-labelled MT-2 (HTLV-I-infected) cell line with anti-Env-5 precipitated the gp68 precursor protein. It was concluded that peptide Env-5 mimics a surface-exposed epitope on the HTLV-I external glycoprotein.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-72-9-2321
1991-09-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jgv/72/9/JV0720092321.html?itemId=/content/journal/jgv/10.1099/0022-1317-72-9-2321&mimeType=html&fmt=ahah

References

  1. Chou P. Y., Fasman G. D. 1978; Prediction of the secondary structure of proteins from their amino acid sequence. Advances in Enzymology 47:45–148
    [Google Scholar]
  2. Clapham P., Nagy K., Weiss R. A. 1984; Pseudotypes of human T-cell leukemia virus type 1 and 2: neutralization by patients’ sera. Proceedings of the National Academy of Sciences, U.S.A. 81:2886–2889
    [Google Scholar]
  3. Gazzolo L., DucDodon M. 1987; Direct activation of resting T lymphocytes by human T-lymphotropic virus type I. Nature, London 326:714–717
    [Google Scholar]
  4. Haseltine W. A., Sodroski J. G., Patarca R. 1985; Structure and function of the genome of HTLV. Current Topics in Microbiology and Immunology 115:177–209
    [Google Scholar]
  5. Horal P., Jeansson S., Rymo L., Svennerholm B., Vahlne A. 1990; Epitope profiles of HTLV-I env and gag gene encoded proteins. In Human Retrovirology: HTLV pp 461–467 Edited by Blattner W. A. New York: Plenum Press;
    [Google Scholar]
  6. Hoshino H., Shimoyama M., Miwa M., Sugimura T. 1983; Detection of lymphocytes producing a human retrovirus associated with adult T-cell leukemia by syncytium induction assay. Proceedings of the National Academy of Sciences, U.S.A 80:7337–7341
    [Google Scholar]
  7. Hudson L., Hay F. C. 1980 Practical Immunology, 2nd. edn Oxford: Blackwell Scientific Publications;
    [Google Scholar]
  8. Jacobson S., Reuben J., Streilein R., Palker T. J. 1991; Induction of CD4+, HTLV-I specific cytotoxic T lymphocytes from patient with HAM/TSP: recognition of an immunogenic region of the gp46 envelope glycoprotein of HTLV-I. Journal of Immunology 146:1155–1162
    [Google Scholar]
  9. Kurata A., Palker T. J., Streilein R. D., Scearce R. M., Haynes B. F., Berzofsky J. A. 1989; Immunodominant sites of human T cell lymphotropic virus type 1 envelope protein for murine helper T cells. Journal of Immunology 143:2024–2030
    [Google Scholar]
  10. Kuroda N., Washitani Y., Shiraki H., Kiyokawa H., Ohno M., Sato H., Maeda Y. 1990; Detection of antibodies to human T-lymphotropic virus type I by using synthetic peptides. International Journal of Cancer 45:865–868
    [Google Scholar]
  11. Lal R. B. 1991; Structural similarity of envelope glycoprotein of HTLV-I and C-terminal region of v-erbB and EGF receptor. AIDS Research and Human Retroviruses 7:459–460
    [Google Scholar]
  12. Lal R. B., Rudolph D. L., Lairmore M. D., Khabbaz R. F., Garfield M., Coligan J. E., Folks T. M. 1991a; Serologic discrimination of HTLV-I and HTLV-II infection by using a synthetic peptide based enzyme immunoassay. Journal of Infectious Diseases 163:41–46
    [Google Scholar]
  13. Lal R. B., Rudolph D. L., Griffic K. P., Kitamura K., Honda M., Coligan J. E., Folks T. M. 1991b; Characterization of immunodominant epitopes of gag and pol gene encoded proteins of human T lymphotropic virus type-I. Journal of Virology 65:1870–1876
    [Google Scholar]
  14. Lerner R. A., Chanock R. M. 1984; Modern Approaches to Vaccines: Molecular and Chemical Basis of Virus Virulence and Immunogenicity. New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
  15. Lerner R. A., Green N., Alexander H., Liu F. T., Sutcliffe J. G., Shinnick T. M. 1981; Chemically synthesized peptides predicted from the nucleotide sequence of the hepatitis B virus genome elicits antibodies reactive with the native envelope protein of Dane particles. Proceedings of the National Academy of Sciences, U.S.A 78:3403–3407
    [Google Scholar]
  16. Palker T. J., Scearce R. M., Copeland T. D., Oroszlan S., Haynes B. F. 1986; C-terminal region of human T-cell lymphotropic virus type I (HTLV-I)pl9 core protein is immunogenic in human and contains an HTLV-I specific epitope. Journal of Immunology 136:2393–2397
    [Google Scholar]
  17. Palker T. J., Tanner M. E., Scearce R. M., Streilein R. D., Clark M. E., Haynes B. F. 1989; Mapping of immunogenic regions of human T-cell leukemia virus type-1 (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46. Journal of Immunology 142:971–978
    [Google Scholar]
  18. Ralston S., Hoeprich P., Aketa R. 1989; Identification and synthesis of the epitope for a human monoclonal antibody which can neutralize human T-cell leukemia/lymphotropic virus type I. Journal of Biological Chemistry 264:16343–16346
    [Google Scholar]
  19. Rosenblatt J. D., Chen I. S. Y., Wachsman W. 1988; Infection with HTLV-I and HTLV-II: evolving concepts. Seminars in Hematology 25:230–246
    [Google Scholar]
  20. Ruegg C. L., Monell C. R., Strand M. 1989; Identification using synthetic peptides of the minimum amino acid sequence from the retroviral transmembrane protein pl5E required for inhibition of lymphoproliferation and its similarity to gp21 of human T-lymphotropic virus types I and II. Journal of Virology 63:3250–3256
    [Google Scholar]
  21. Seiki M., Hattori S., Hirayama R., Yoshida M. 1983; Human adult T-cell leukemia virus complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA. Proceedings of the National Academy of Sciences, U.S.A 80:3618–3622
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-72-9-2321
Loading
/content/journal/jgv/10.1099/0022-1317-72-9-2321
Loading

Data & Media loading...

Most cited Most Cited RSS feed